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Abstract
It is becoming widely accepted that psychoactive drugs, often abused by HIV-I infected individuals, can significantly alter
the progression of neuropathological changes observed in HIV-associated neurodegenerative diseases (HAND). The
underlying mechanisms mediating these effects however, remain poorly understood. In the current study, we explored
whether the psychostimulant drug cocaine could exacerbate toxicity mediated by gp120 in rat primary astrocytes. Exposure
to both cocaine and gp120 resulted in increased cell toxicity compared to cells treated with either factor alone. The
combinatorial toxicity of cocaine and gp120 was accompanied by an increase in caspase-3 activation. In addition, increased
apoptosis of astrocytes in the presence of both the agents was associated with a concomitant increase in the production of
intracellular reactive oxygen species and loss of mitochondrial membrane potential. Signaling pathways including c-jun N-
teminal kinase (JNK), p38, extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinases (MAPK), and nuclear
factor (NF-kB) were identified to be major players in cocaine and gp120-mediated apoptosis of astrocytes. Our results
demonstrated that cocaine-mediated potentiation of gp120 toxicity involved regulation of oxidative stress, mitochondrial
membrane potential and MAPK signaling pathways.
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Introduction
AIDS or acquired immunodeficiency syndrome is a multisystem
disorder involving the central nervous system (CNS). Human
immunodeficiency virus type 1 (HIV-1) infection of the brain leads
to a range of neurodegenerative complications, often referred to as
HAND [1]. The most severe form of HAND, HIV-associated
dementia (HAD), is characterized by neuropathological changes
that include reactive astrocytosis and formation of microglial
nodules and multinucleated giant cells in a setting of enhanced
virus replication and/or cellular activation [2]. While CD4
lymphocytes and microglia/macrophages are the major target
cells for HIV-1 infection [3], limited infection has also been
observed in astrocytes [4].
Astrocytes, the major non-neuronal cells in the brain, have been
implicated in providing tropic support for the neurons. Typically
these functions include segregation, maintenance, and support of
neurons, including clearance and release of extracellular glutamate
[5,6], scavenging of oxygen free radicals [7] and homeostatic
maintenance of extracellular ionic environment and pH [8,9]
These functions provide metabolic substrates for neurons [10], and
couple cerebral blood flow to neuronal activity [11]. It is thus
plausible to envision that dysregulation of astrocyte-specific
functions, can critically impact neuronal survival [12]. It has been
shown that progression of HAD is also accompanied by apoptosis
of astrocytes [13,14,15]. Significantly, greater numbers of
apoptotic astrocytes have been detected in the brains of HIV/
AIDS patients with rapidly progressing dementia [16], and
detection of apoptotic astrocytes appeared to be more common
in patients with dementia, compared to non-demented HIV/
AIDS patients [14], suggesting a role for astrocytic cell loss in the
neuropathogenesis of HAD.
Mounting evidence suggests that drugs of abuse such as cocaine
can accelerate the incidence and progression of HAD [17,18,19].
For example, drug-abusing HIV-1-positive individuals exhibit
more severe cognitive impairment compared with the non-drug-
abusing HIV-positive counterparts. Despite the recognized impact
of drugs of abuse on the clinical course of HIV-associated brain
pathology, little is known about mechanisms that underlie the
ability of these drugs to enhance toxic effects of HIV-1 proteins in
the brain. Emerging concepts suggest that psychostimulants such
as cocaine can have profound effects on the susceptibility of
neuronal cells to HIV-1 virotoxins. However, whether cocaine can
also potentiate the toxic effect of HIV-1 gp120 on astrocytes
remains unclear.
In the present study, we hypothesized that increased progression
and incidence of HAD-associated astrocytic cell death in drug-
abusing HIV-infected individuals could be attributed to the
potentiation by cocaine of gp120-induced apoptosis. In this report
we have dissected the converging signaling pathways including the
c-jun N-teminal kinase (JNK), p38 and extracellular signal-
regulated kinase (ERK)/mitogen-activated protein kinase (MAPK)
pathways and the downstream transcription factor NF-kB, leading
to cocaine and gp120-mediated apoptosis of astrocytes.
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Animals
Pregnant female Sprague-Dawley rats were purchased from
Charles River Laboratories, Inc. (Wilmington, MA). All of animals
were housed under conditions of constant temperature and
humidity on a 12-h light, 12-h dark cycle, with lights on at
0700 h. Food and water were available ad libitum. All animal
procedures were performed according to the protocols approved
by the Institutional Animal Care and Use Committee of the
University of Nebraska Medical Center and National Institute of
Health.
Reagents
Viral gp120 (IIIB strain) was a gift from Marcus Kaul (Burham
Institute for Medical Research), gp120 (Bal) was obtained the
AIDS Research and Reference Reagent Program of National
Institutes of Health. The rationale for choosing gp120 IIIB is
based on the utilization of CXCR4 co-receptor in astrocytes.
Quantification of gp120 in the CNS or CSF has been difficult
because of the limited cross-reactivity of anti-gp120 Abs. The
relevance of using 200 ng/ml (or 1670 pM) of gp120 in our study
is based on the reports that levels as high as 796 ng/ml of gp120
have been detected in HIV-infected subjects during early infection
[20] and furthermore, that these concentrations have also been
used in earlier reports for neuronal toxicity by others and us
[21,22,23]. Additionally, Brenneman et al have also demonstrated
gp120 neurotoxicity in mouse hippocampal neuronal-glial cell
cultures at concentrations ranging from below 1 pM to 1 nM [24].
The specific MAPK/ERK kinase (MEK) 1/2 inhibitor U0126,
p38 inhibitor SB203580, and JNK inhibitor SP600125 were
purchased from Calbiochem (San Diego, CA). Nuclear factor
(NF)-kB inhibitor l-1-tosyllamide-2-phenylethyl chloromethyl ke-
tone (TPCK) was purchased from Sigma Chemicals (St. Louis,
MO).
Primary astrocyte cultures. Rat primary astrocytes were
prepared according to the previously described protocol with slight
modifications [25]. Briefly, tissues from whole brains of postnatal
(P1–P2) Sprague-Dawley rats were triturated and cells were plated
on poly-D-lysine pre-coated cell culture flasks in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovin serum,
100 U/ml penicillin and 100 mg/ml streptomycin. Cultures were
maintained at 37uC in a humidified atmosphere of 5% CO2/95%
air. After reaching a confluent monolayer of glial cells (10–14
days), microglia were separated from astrocytes by shaking off.
The enriched astrocytes were .96% positive for glial fibrillary
acidic protein when assessed by immunocytochemical staining.
MTT assay. Cell viability was measured by 3-(4,5-
dmethylthiazol-2-yl)-2,5-diphenyl Tetrazolium bromide (MTT)
method. Briefly, cells were collected and seeded in 96-well
plates. Different seeding densities were optimized at the
beginning of the experiments. Rat primary astrocytes were
exposed to fresh medium containing various concentrations of
cocaine (1, 10, 100 mM) with or without 200 ng/ml gp120. After
incubation for up to 48 h, 20 ml MTT tetrazolium salt dissolved in
Hank’s balanced salt solution at a final concentration of 5 mg/ml
was added to each well and incubated in CO2 incubator for 4 h.
Finally, the medium was aspirated from each well and 200 mlo f
dimethyl sulfoxide was added to dissolve the formazan crystals and
the absorbance of each well was obtained using a plate counter at
test and reference wavelengths of 570 nm and 630 nm,
respectively. All of experiments were repeated at least four times.
Immunocytochemistry. Cells were fixed in 4% paraforma-
ldehyde, followed by blocking with phosphate-buffered saline
(PBS) containing 10% normal goat serum. After blocking, cells
were incubated at 4uC overnight with the anti-cleaved caspapse-3
antibody (Cell signaling, Danvers, MA). Following washes, cells
were then incubated with the secondary goat anti-rabbit Alexa
Fluor 488-conjugated antibody (1:500). For negative controls, cells
were treated as described above, except that the primary antibody
treatment was omitted. All experiments were repeated at least
three times.
Reactive oxygen species (ROS) assay. Intracellular pro-
duction of ROS was measured by 29,79-dichlorfluorescein
diacetate (DCFH-DA) oxidation. Primary astrocytes were treated
with cocaine and/or gp120 for 1 h and then incubated with
DCFHDA (Sigma, St. Louis, MO) at 20 mM for 30 min. After
incubation, cells were washed with PBS and the fluorescence was
visualized immediately at wavelengths of 485 nm for excitation
and 530 nm for emission using an inverted fluorescence
microscope. Total green fluorescence intensities in every well
were quantitated using NIH Image J software. All of experiments
were repeated at least three times.
Analysis of mitochondrial membrane depolariza-
tion. The change in mitochondrial membrane potential in the
astrocytes was monitored using the mitochondrial membrane
potential detection kit (Cayman Chemical Company) according to
the manufacturer’s instructions. Briefly, rat primary cultured
astrocytes cultured in either 24-well plate (1610
5 cells per well) or
96-well plate (3610
4 cells per well) were treated with gp120 and/
or cocaine followed by treatment with 16JC-1 reagent diluted in
serum-free culture medium for 20 min at 37uCi n5 %C O 2.
Thereafter, cells were rinsed once in 16rinsing buffer provided in
the kit. Uptake of the dye was then assessed using the Nikon
inverted fluorescence microscope TE2000-E (Nikon, Tokyo,
JAPAN). Fluorescence was also measured using the FL600
fluorescent plate reader (Bio-Tek Instruments, Winooski, VT) at
the excitation wavelengths of 485 nm and 535 nm. Fluorescence
intensity also was quantified using NIH Image J software. All
experiments were repeated at least three times.
Western blotting. Treated cells were lysed using the
Mammalian Cell Lysis kit (Sigma, St. Louis, MO) and the NE-
PER Nuclear and Cytoplasmic Extraction kit (Pierce, Rockford,
IL). Equal amounts of the corresponding proteins were
electrophoresed in sodium dodecyl sulfate polyacrylamide gels
(12%) under reducing conditions followed by transfer to PVDF
membranes. Blots were blocked with 5% nonfat dry milk in
phosphate buffered saline and probed with antibodies recognizing
the phosphorylated forms of JNK, p38, ERK1/2 (Cell Signaling,
Danvers, MA; 1:500), cleaved Caspase-3 (Cell Signaling, Danvers,
MA; 1:500) and NF-kB p65 (Cell Signaling, Danvers, MA;
1:1000). The secondary antibodies were alkaline phosphatase-
conjugated to goat anti mouse/rabbit immunoglobulin G (IgG)
(1:5000). Signals were detected by chemiluminescence (Pierce,
Rockford, IL).
Statistical analysis. Data were expressed as mean6SD.
Significance of differences between control and cocaine-treated
samples was determined by one-way ANOVA followed by the post
hoc Least-Significant-Difference (LSD) test. Values of p,0.05
were considered to be statistically significant.
Results
Cocaine exposure resulted in enhanced gp120 toxicity in
rat primary astrocytes
To explore the toxic effects of cocaine and gp120, rat primary
astrocytes were exposed to varying concentrations of cocaine (1,
10, 100 mM) with or without gp120IIIB (200 ng/ml) for 48 h
Cocaine/gp120 and Astrocyte
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rationale for choosing the above mentioned range of cocaine was
based on the following reports. In human volunteers, plasma
cocaine concentrations following intranasal administration of
1.5 mg/kg cocaine often range between 0.4 to 1.6 mM [26], while
plasma cocaine concentrations in tolerant abusers, reach levels of
up to 13 mM [27]. Additionally, cocaine concentrations of up to
100 mM and higher have been reported in postmortem brains of
chronic human cocaine users following acute intoxication [28].
Based on these reports, we rationalized that cocaine concentra-
tions ranging from 1 to 100 mM would be comparable to levels
observed in humans. As shown in Figure 1A, increasing
concentrations of cocaine (1, 10, 100 mM) resulted in decreasing
cell viability by 18% (p,0.05), 14% (p,0.05), and 20% (p,
0.001), respectively. Interestingly, exposure of cells to 1 mM
cocaine resulted in reduction of cell viability by 18%; gp120 alone,
as expected, decreased cell viability by 20%, and both gp120 and
cocaine together caused a statistically significant decrease in cell
viability by about 29% (p,0.05 versus cocaine or gp120). On the
other hand, heat-inactivated gp120 or CCR5-utilizing strain of
gp120 (Bal) failed to exert toxicity on astrocytes (Figure 1B),
thereby underpinning the specificity of gp120 IIIB toxicity on
astrocytes.
Cocaine enhanced gp120-mediated activation of
caspase-3
To corroborate the findings that cocaine and gp120-mediated
toxicity involved the apoptotic pathway, we next sought to
investigate activation of caspase-3. As shown in Figure 2A,
astrocytes treated with either gp120 or cocaine for 24 h
demonstrated positive staining for activated caspase-3. Simulta-
neous treatment of astrocytes with both the agents resulted in
further enhancement of caspase-3 positivity. These findings were
further validated by Western blot analysis for activated caspase-3.
As shown in Figure 2B and 2C, astrocytes treated with either
gp120 or cocaine alone demonstrated a significant increase in
expression levels of activated caspase-3 compared with untreated
control cells (p,0.05 versus control). Treatment of astrocytes with
a combination of both gp120 and cocaine, however, further
Figure 1. Effects of cocaine and/or gp120 on cell viability in rat primary astrocytes. (A) Effects of 1, 10, 100 mM cocaine in the presence or
absence of gp120 IIIB (200 ng/ml) for 48 h on the survival of rat primary astrocytes using the MTT assay. (B) Effects of gp120 IIIB, heated inactivated
gp120 IIIB and gp120 Bal (200 ng/ml) on the survival of rat primary astrocytes using the MTT assay. All the data are presented as mean 6 SD of four
individual experiments. *p,0.05; **p,0.01; ***p,0.001 versus control group; # p, 0.05 versus cocaine group; ‘ p, 0.05 versus gp120 group.
doi:10.1371/journal.pone.0013427.g001
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exposed to either agent alone (p,0.05 versus cocaine or gp120).
Cocaine and gp120-mediated alterations in intracellular
reactive oxygen species (ROS)
ROS production plays a critical role in the mitochondrial
dysfunction and subsequent cell death. We next sought to explore
whether cocaine-mediated enhancement of the gp120 toxicity also
involved production of ROS. Briefly, rat primary astrocytes were
treated as described above followed by measurement of intracel-
lular ROS using the DCHF-DA oxidation assay. As shown in
Figures 3A and B, treatment of astrocytes with cocaine or gp120
alone resulted in increased intracellular ROS production was
increased to 161% and 148% in the presence of cocaine and
gp120 respectively, compared with untreated cells (p,0.01). This
effect was augmented to 236% in the simultaneous presence of
both cocaine and gp120 (p,0.001 versus control, p,0.05 versus
cocaine or gp120 alone).
Cocaine and gp120-mediated alterations in
mitochondrial membrane potential
Mitochondria are a link between the initial insult stimuli and the
initiation of apoptosis. Furthermore, since loss of mitochondrial
membrane potential (Dym), a consequence of mitochondrial
membrane permeability is detected in several models of apoptosis,
we sought to detect whether cocaine and/or gp120-mediated
apoptosis involved change in ym in astrocytes (Figure 4).
Astrocytic mitochondrial membrane depolarization was assessed
following exposure of cells to cocaine and/or gp120 for 18 h using
JC-1 probe, which is a fluorescent lipophilic cationic dye that
accumulates in mitochondria in proportion to the Dym, that
normally exists across the inner mitochondria membrane [29]. As
shown in Figures 4A and 4B, there was increased membrane
depolarization in astrocytes exposed to either gp120 or cocaine
alone by 66% or 67%, respectively (p,0.01 versus control), and
this effect was further enhanced in the presence of both cocaine
and gp120 by 45% (p,0.05 versus cocaine or gp120 alone).
Figure 2. Effects of cocaine and/or gp120 exposure on caspase-3 activation in rat primary astrocytes. (A) Rat primary astrocytes treated
with cocaine (10 mM) and/or gp120 IIIB (200 ng/ml) for 24 h were monitored for active caspase-3 by immunostaining using anti-cleaved caspase-3
antibody. Scale bars indicate 20 mm. (B) Rat primary astrocytes were treated with cocaine and/or gp120 for 24 h, followed by cell lysis and detection
of anti-cleaved caspase-3 protein on a Western blot. (C) Densitometry scans of the ratio of band intensities of cleaved caspase-3/b-actin from three
separate experiments. * p,0.05 versus control group; # p, 0.05 versus cocaine group; ‘p, 0.05 versus gp120 group.
doi:10.1371/journal.pone.0013427.g002
Cocaine/gp120 and Astrocyte
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astrocytes
Increasing evidence indicates that MAPK pathway plays an
important role in apoptosis [30]. We next sought to investigate
whether cocaine and/or gp120-mediated astrocyte apoptosis
involved activation of MAPK signaling mediators. Cell lysates
from astrocytes treated with cocaine and/or gp120 were assessed
for activation of MAPK pathway signaling proteins using Western
blot. Treatment of astrocytes with both cocaine and gp120
resulted in a transient time-dependent increase in phosphorylation
of JNK, p38 and ERK (Figure 5) with maximal activation at
15 min post-treatment and a decline thereafter that was sustained
even at 48 h compared with control cells (Figure 5).
As shown in Fig 6A–C, there was increased activation of JNK,
p38 and ERK1/2, in the presence of cocaine or gp120 alone and,
this effect was further enhanced in the presence of both the agents.
As expected, heat-inactivated gp120 failed to induce gp120-
mediated phosphorylation of these MAPKs. The specificity of
these MAPKs in the enhancement of cell toxicity was further
confirmed by pre-treating the cells with pharmacological inhibitors
specific for the respective signaling pathways (Figure 6 D–F). As
shown in the Figures 6 (G–I), pretreatment of cells with JNK
(SP600125; 20 mM), p38 (SB203580; 20 mM), or MEK1/2
(U0126, 20 mM) inhibitors for 1 hr followed by treatment with
cocaine and gp120 resulted in amelioration of cell toxicity, further
confirming the role of these pathways in the co-operative toxicity
induced by these agents.
Cocaine and gp120-mediated NF-kB increase in
astrocytes
Activation of the MAPK cascade has been shown to result in
translocation of the downstream transcription factor kappa-B (NF-
kB) [31]. Nuclear extracts isolated from rat primary astrocytes
treated with cocaine and gp120 were examined for the
translocation of the p65 subunit of NF-kB using immunocyto-
chemical analysis. As shown in Figure 7A, there was an increased
translocation of NF-kB p65 in the nucleus of cocaine and gp120-
treated cells versus the untreated control cells. Further validation
of these findings was done by Western blot analysis. As shown in
the Figure 7B, treatment of astrocytes with both the agents
induced time-dependent nuclear translocation of NF-kB p65, an
effect that was evident as early as 5 min post-treatment and that
was sustained for at least 60 min. To further confirm the role of
NF-kB in the toxicity induced by cocaine and gp120, astrocytes
cultures were pre-treated with l-1-tosyllamide-2-phenylethyl chlor-
omethyl ketone (TPCK), an inhibitor of NF-kB, followed by
treatment of cells with both the agents. Toxicity induced by
cocaine and gp120 was significantly abrogated in the presence of
the NF-kB p65 inhibitor TPCK (Figure 7C), thus confirming the
involvement of NF-kB activation in mediating cocaine and gp120
neurotoxicity.
Discussion
While astrocyte proliferation is one of the hallmark features of
HAD, increasing evidence implies that astrocytic apoptosis could
also participate in many neurodegenerative disorders including
HAD [14,32,33,34,35,36],and furthermore, that astrocytic dys-
function could contribute to neuronal loss and overall pathology
[12]. This thinking is plausible since astrocytes provide neuro-
trophic support, not only by protecting neurons against toxicity
induced by excitatory amino acids but also by maintaining normal
homeostasis of the extracellular fluid. Hence, keeping in the mind
the concept that astrocytic cell death could be induced by HIV env
protein, gp120, the present study was undertaken to understand
the mechanisms by which cocaine could amplify the toxic response
of gp120.
Our findings suggested that cocaine in cooperation with gp120
exacerbated toxicity in rat astrocytic cultures via the apoptotic
pathway involving intracellular ROS production, mitochondrial
membrane potential loss, and activation of the MAPK signaling
pathways and NF-kB. Our results demonstrated that co-treatment
of rat primary astrocytes with cocaine and gp120 caused a
significant decrease in cell viability compared with cells treated
with either agent alone. Apoptosis or programmed cell death is a
consequence of concerted activation of proteolytic cascade
involving a family of proteases such as caspase-3. To dissect the
Figure 3. Effects of cocaine and/or gp120 on intercellular ROS production in rat astrocytes. (A) Cells treated with cocaine in the absence
or presence of gp120 for 1 h were assessed for production of ROS using DCFH-DA assay. Treatment of astrocytes with cocaine and/or gp120 resulted
in increased ROS production. Scale bars indicate 200 mm. (B) Quantification of ROS fluorescence intensity in cells treated with gp120 and/or cocaine
using fluorescence plate reader. All the data are presented as mean 6 SD of four individual experiments. ** p,0.01; ***p,0.001 versus control group;
## p, 0.01 versus cocaine group; ‘‘ p, 0.01 versus gp120 group.
doi:10.1371/journal.pone.0013427.g003
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toxicity, activation of caspase-3 was monitored in treated cells
using both immunostaining and Western blot analyses. Indeed
there was increased activation of caspase-3 in cells treated with
both the agents compared with cells treated with either agent
alone.
Mitochondrial dysfunction and oxidative stress occur early
during the apoptotic pathway and is a common feature of most
neurodegenerative disorders. Moreover, there is strong evidence
that both mitochondrial dysfunction and oxidative stress are causal
factors in the pathophysiology of these disorders [37,38,39]. It has
been shown that ROS generated in astrocytes can have
implications in eliciting oxidative stress to the neighboring neurons
[40]. In the present study, co-treatment of rat primary astrocytes
with both cocaine and gp120 resulted in enhanced ROS
production compared with the astrocytes treated with either agent
alone.
Work by various groups has suggested the mitochondria as a
link between the initial apoptotic signal and the end point
biochemical reactions leading to cell death [41,42]. Mitochondria
play a critical role in the regulation of ROS production and cell
death. Mitochondrial dysfunction is thus a prominent feature of
apoptosis, and release of pro-apoptotic protein from the
mitochondrial intermembrane space has been considered to be a
critical event that occurs during apoptosis [43]. In response to
death stimuli, mitochondrial membranes become permeabilized,
ultimately resulting in activation of initiator and effector caspases
[44]. In the present study, co-treatment of primary astrocytes with
both cocaine and gp120 resulted in a significant decrease in
mitochondrial membrane potential compared with cells treated
with either agent alone.
Intracellular signaling mechanisms responsible for gp120 effects
in glial cells have not been clearly identified. It has been previously
been shown that gp120 can activate the MAPK pathway [45,46].
Figure 4. Effects of cocaine and/or gp120 on mitochondrial membrane potential in rat astrocytes. (A) Cells treated with cocaine and/or
gp120 for 18 h were assayed for mitochondrial membrane potential by staining with JC-1 dye. Treatment with cocaine/gp120 resulted in reduction of
the aggregation of JC-1 dye in the mitochondria (red fluorescence) and decreased ratio of the aggregate (red fluorescence) to monomer JC-1 (green
fluorescence) in the cells. Scale bars indicate 200 mm. (B) Quantification of Dym expressed as a ratio of J-aggregate to JC-1 monomer (red: green)
fluorescence intensity. All the data are presented as mean6SD of three individual experiments. ** p,0.01; ***p,0.001 versus control group; #p,
0.05 versus cocaine group; ‘p, 0.05 versus gp120 group.
doi:10.1371/journal.pone.0013427.g004
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turn, modulate diverse cellular events, such as cell death and
survival [47,48,49]. Activation of JNK, p38 and ERK pathway in
cell death has been well documented [48,49]. In present study,
treatment of astrocytes with cocaine and/or gp120 led to a
significant increase in JNK, p38 and ERK/MAPK pathway,
thereby underpinning the role of this pathway in cocaine and
gp120-mediated apoptosis.
To further validate the role of JNK, p38 and ERK/MAPK
signaling pathway in cocaine/gp120-induced astrocytic apoptosis,
cells were pretreated with inhibitors specific for JNK (SP600125),
p38 (SB203580), and MEK1/2 (U0126) prior to exposure with
Figure 5. Cocaine and gp120 induced phosphorylation of MAPKs. Western blot analysis of time-dependent activation of ERK, JNK and p38
kinases in astrocytes treated with cocaine and gp120. Representative immunoblots are presented from 4 separate experiments.
doi:10.1371/journal.pone.0013427.g005
Figure 6. Involvement of MAPK pathway in cocaine and/or gp120-induced toxicity in rat primary astrocytes. (A–C) Western blot
analysis of cytosolic lysates from cocaine (10 mM) and/or gp120 IIIB (200 ng/ml) or heat-inactivated gp120 IIIB)-treated cells (15 min) using antibodies
specific for the phosphorylated forms of JNK, p38, ERK/MAPK respectively. (D–F) Densitometric analyses of phos-JNK/b-actin, phos-p38/b-actin, phos-
ERK/ERK from three separate experiments. Representative immunoblot and the densitometric analysis of phos-JNK/b-actin, phos-p38/b-actin, phos-
ERK/ERK from three separate experiments is presented. All the data in these figures are presented as mean6SD of three individual experiments.
**p,0.01; ***p,0.001 versus control group; #p, 0.05, ## p,0.01 versus cocaine group; ‘ p,0.05 versus gp120 group. (G–I) Pharmacological
inhibition of the MAPK pathway in astrocytes resulted in abrogation of cocaine and gp120-induced toxicity. All the data are presented as mean6SD
from three individual experiments. **p,0.01 versus control group. #p,0.05, ##p,0.01 versus cocaine + gp120 group.
doi:10.1371/journal.pone.0013427.g006
Cocaine/gp120 and Astrocyte
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Inhibition of JNK, p38 and ERK/MAPK pathway by their
respective inhibitors ameliorated cell toxicity induced by cocaine
and gp120.
Next step was to examine the role of downstream mediator of
the MAPK pathway, the transcripotion factor NF-kB, which
translocates into the nucleus upon activation to initiate transcrip-
tion of various target genes [50]. Our findings clearly demon-
strated enhanced nuclear translocation of NF-kB in astrocytes
treated with both cocaine and gp120, and this effect was abrogated
in the cells pretreated with the NF-KB inhibitor.
In conclusion, the present study indicates that both cocaine or
gp120 elicit similar signaling transduction pathway in astrocytes,
involving oxidative stress, mitochondrial membrane potential
loss, activation of JNK, p38 and ERK/MAPK pathways and
resulting downstream activation of nuclear transcription factor
NF-kB. Simultaneous treatment of astrocytes with both the
agents, however, leads to an even further activation of the
signaling pathways culminating eventually into enhanced astro-
cytic apoptosis. Such a process could have deleterious ramifica-
tions for neuronal survival, especially in areas close to the
apoptosing astrocytes. Such a mechanism could have implications
for not only HAD, but also other neurodegenerative disorders
that have co-morbid association with drugs of abuse. In the
central dogma, thus while astrocyte proliferation or astrocytosis is
thought of as a major correlate of HAD, it is important to
consider contributions of astrocytic death in neuronal survival.
Finally, defining the molecular pathways activated in response to
drugs of abuse and viral toxins could help pave the way for
designing therapeutic strategies aimed at treatment of HAD in
drug-abusing population.
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Figure 7. NF-kB is involved in cocaine and gp120-induced astrocyte apoptosis. (A) Rat primary astrocytes grown on coverslips were treated
with cocaine (10 mM) and/or gp120 IIIB (200 ng/ml) for 15 min and stained with an anti-NF-kB p65 antibody, followed by treatment with an Alexa
Flour 488-conjugated secondary antibody. Slides were mounted in Slow Fade antifade reagent (with DAPI, blue nuclear stain) and images were
captured by fluorescence microscope. Scale bars indicate 20 mm. (B) Western Blot analysis of nuclear extracts from cocaine and gp120-treated cells
for varying times (5 to 60 min) using an antibody specific for p65 subunit of NF-kB. Representative immunoblot and the densitometric analysis of p
NF-kB/histone from three separate experiments is presented. All the data in these figures are presented as mean6SD of three individual experiments.
*p,0.05 versus control group. (C) Inhibition of NF-kB using the specific inhibitor TPCK (10 mM) resulted in abrogation of cocaine and gp120 toxicity.
**p,0.01 versus control group. # p,0.05 versus cocaine + gp120 group.
doi:10.1371/journal.pone.0013427.g007
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